Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.72 |
| ▸ | CA1 | P00915 | 2/20 | 0.72 |
| ▸ | CA2 | P00918 | 2/20 | 0.72 |
| ▸ | CA7 | P43166 | 2/20 | 0.72 |
| ▸ | CA9 | Q16790 | 2/20 | 0.72 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.72 |
| ▸ | NPC1 | O15118 | 2/20 | 0.72 |
| ▸ | RAB9A | P51151 | 2/20 | 0.72 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.72 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.72 |
| ▸ | HPGD | P15428 | 3/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.70 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.62 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.62 |
| ▸ | PGR | P06401 | 2/20 | 0.62 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Dioxane SCHEMBL28341218 | 0.90 | NPC1 (0.60) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17904269 | 0.87 | NPC1 (0.70) | CA12CA1CA2CA7CA9 | |
| SCHEMBL14292891 | 0.85 | LMNA (0.77) | CA12CA1CA2CA7CA9 | |
| SCHEMBL12634385 | 0.85 | APP (0.64) | CA12CA1CA2CA7CA9 | |
| SCHEMBL3467699 | 0.85 | NPC1 (0.54) | CA12CA1CA2CA7CA9 | |
| Methyl 2-Hydroxy-5-Methoxybenzoate SCHEMBL29709382 | 0.85 | CA1 (0.72) | CA12CA1CA2CA7CA9 | |
| SCHEMBL11324398 | 0.85 | NPC1 (0.72) | CA12CA1CA2CA7CA9 | |
| Methyl 2-Hydroxy-5-Methoxybenzoate SCHEMBL643758 | 0.85 | CA1 (0.72) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4212043 | 0.84 | MAOB (0.58) | CA12CA1CA2CA7CA9 | |
| Methyl 2,4-Dihydroxybenzoate SCHEMBL30917273 | 0.84 | CA12 (1.00) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 570 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118852129-A | Preparation method and application of triazole feed additive with anti-inflammatory activity designed based on deep learning technology | 河南湾流生物科技有限公司 | 2024-10-29 | — | — | CN | claimed |
| US-20230148641-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2023-05-18 | — | — | US | claimed |
| EP-4125427-A1 | FLAVOR COMPOSITION | Firmenich SA (CH) | 2023-02-08 | — | — | EP | claimed |
| WO-2021198199-A1 | FLAVOR COMPOSITION | FIRMENICH SA (CH) | 2021-10-07 | — | — | WO | claimed |
| CN-109541045-A | The active components content assaying method such as a kind of halimasch and its product Asclerol | 吉林农业大学 | 2019-03-29 | — | — | CN | claimed |
| US-10191398-B2 | Electrophotographic photoconductor, image forming apparatus, and process cartridge | RICOH COMPANY, LTD. (JP) | 2019-01-29 | — | — | US | claimed |
| EP-3710462-B1 | BRARTEMICIN ANALOGUES | VICTORIA LINK LTD (NZ) | 2026-05-13 | — | — | EP | disclosed |
| US-20260101914-A1 | VANILLA COMPOSITION | FIRMENICH & CIE (CH) | 2026-04-16 | — | — | US | disclosed |
| US-12576055-B2 | Disease detection and treatment based on trimethyl-lysine levels | THE CLEVELAND CLINIC FOUNDATION (US) | 2026-03-17 | — | — | US | disclosed |
| EP-4680039-A1 | COMPOSITIONS FOR REDUCING OFF NOTES AND USES THEREOF | DSM-Firmenich AG (CH) | 2026-01-21 | — | — | EP | disclosed |
| US-20250377364-A1 | REAGENT, METHOD, AND DEVICE FOR DETECTING ALBUMIN | NEC CORPORATION (JP) | 2025-12-11 | — | — | US | disclosed |
| WO-2025106974-A1 | PRODRUG MOIETIES AND COMPOUNDS COMPRISING THE SAME | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-05-22 | — | — | WO | disclosed |
| WO-2024251755-A1 | COMPOSITIONS FOR REDUCING OFF NOTES AND USES THEREOF | DSM-FIRMENICH AG (CH) | 2024-12-12 | — | — | WO | disclosed |
| US-4604390-A | FUNGICIDES, ANTITUMOR AGENTS | WARNER-LAMBERT COMPANY (US) | 1986-08-05 | — | — | US | disclosed |
| EP-0187487-A1 | Benzothiophenes and benzofurans having antiallergic activity | WARNER-LAMBERT COMPANY (US) | 1986-07-16 | — | — | EP | disclosed |
| EP-0172632-A1 | Benzopyrano[4,3,2-cd]indazole compounds, processes for their production and pharmaceutical compositions comprising the compounds | WARNER-LAMBERT COMPANY (US) | 1986-02-26 | — | — | EP | disclosed |
| US-4426332-A | FROM A 1,3-CYCLOHEXANEDIONE AND OXYGEN, COPPER CATALYST, HYDROGEN HALIDE OR THIONYL CHLORIDE, SOLVENT | BASF AKTIENGESELLSCHAFT (DE) | 1984-01-17 | — | — | US | disclosed |
| US-4146631-A | ANTIALLERGENS, RESPIRATORY DISORDERS | MAY & BAKER LIMITED (GB) | 1979-03-27 | — | — | US | disclosed |
| US-4024160-A | Substituted 2-amino chromones and process for the preparation thereof | WARNER-LAMBERT COMPANY (US) | 1977-05-17 | — | — | US | disclosed |
| US-3932466-A | Substituted 2-amino chromones and process for the preparation thereof | WARNER-LAMBERT COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260101914-A1 | VANILLA COMPOSITION | TAS2R19, TAS2R9, TAS2R39 | CA12 2475/4885CA1 4358/4885CA2 3232/4885 |
| US-20250377364-A1 | REAGENT, METHOD, AND DEVICE FOR DETECTING ALBUMIN | ALB, TTR, MTTP | CA12 367/4885CA1 1488/4885CA2 3341/4885 |
| US-12576055-B2 | Disease detection and treatment based on trimethyl-lysine levels | BHMT, BHMT2, EHMT2 | CA12 1832/4885CA1 2402/4885CA2 1446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.